What is the current market size?

The Companion Animal Blood Glucose Monitoring market size reached USD 1.2 billion in 2023, driven by rising pet diabetes prevalence and advanced veterinary diagnostics.

What is the expected growth rate?

The market is projected to grow at a CAGR of 5.5% from 2026 to 2033, fueled by demand for non-invasive monitoring and expanding veterinary care access.

What are the key growth drivers?

Key drivers include increasing pet obesity rates, technological innovations in wearable devices, and heightened pet owner awareness about chronic disease management.

What challenges does the market face?

Challenges include high device costs, regulatory compliance complexities, and limited pet owner reimbursement options in emerging markets.

Which regions lead the market?

North America dominates the market, followed by Europe, due to established veterinary infrastructure and high pet adoption rates.

Who are the top companies?

Key players include Abaxis, Inc., VetScan, and Zoetis, focusing on product innovation and partnerships with veterinary clinics.

What future opportunities exist?

Opportunities lie in Asia-Pacific market expansion, telemedicine integration, and development of disposable, cost-effective monitoring solutions.

How is technology impacting the market?

Advancements in continuous glucose monitoring (CGM) and AI-driven analytics are enhancing accuracy and enabling real-time data tracking for pets.

What is the regulatory landscape?

Regulatory frameworks by the FDA and EMA require rigorous clinical trials, ensuring safety but also creating barriers for new entrants in the market.

What is the future outlook?

The market's future outlook remains positive, with anticipated growth from smart devices, remote monitoring, and increased veterinary insurance adoption.

Companion Animal Blood Glucose Monitoring Market Growing at CAGR — 2026 Report

Companion Animal Blood Glucose Monitoring by Application (Veterinary Reference Laboratories, Veterinary Hospitals and Clinics, Point-of-care/In-house Testing, Research Institutes and Universities), by Types (Blood Glucose Strips, Glucose Monitors, Urine Glucose Strips), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 91

Forecast Period: 2026 - 2033

Market Size: $667 million

CAGR: 5%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 91

Forecast Period: 2026 - 2033

Market Size: $667 million

CAGR: 5%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Companion Animal Blood Glucose Monitoring Market Size | CAGR 5% Forecast 2033

Companion Animal Blood Glucose Monitoring Market Growing at CAGR — 2026 Report

🏭 Healthcare🌍 Global

Pages: 91

Forecast Period: 2026 - 2033

Market Size: $667 million

CAGR: 5%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 91

Forecast Period: 2026 - 2033

Market Size: $667 million

CAGR: 5%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Companion Animal Blood Glucose Monitoring Market Overview

The Companion Animal Blood Glucose Monitoring market focuses on devices and systems designed to measure blood glucose levels in domesticated animals, primarily dogs and cats, to manage diabetes mellitus. This market is critical for improving the quality of life for pets and ensuring precise glycemic control in veterinary care. The Companion Animal Blood Glucose Monitoring market size is projected to grow significantly, driven by rising pet ownership, advancements in non-invasive monitoring technologies, and increased awareness of chronic disease management in animals. With a growth outlook of 7.2–8.5% CAGR from 2026–2033, the market forecast highlights robust industry expansion, fueled by macroeconomic tailwinds and regulatory support for veterinary diagnostics.

Loading chart…

North America dominates the market in 2026, accounting for ~42% of total revenue, driven by high adoption rates of advanced veterinary diagnostics and a well-established pet healthcare ecosystem. Meanwhile, the Asia-Pacific region is the fastest-growing market, with a CAGR of 9.1%, propelled by urbanization, rising disposable incomes, and growing awareness of pet health. Key industry expansion factors include the development of user-friendly, pet-specific monitoring systems, regulatory approvals for animal use, and partnerships between veterinary clinics and diagnostic device manufacturers. Supply-chain dynamics, such as the availability of biosensors and polymer-based reagents, also play a pivotal role in shaping competitive intensity and innovation cycles.

Report Overview

Report Attribute	Details
Market size value in 2025	667.00 million
Revenue forecast in 2033	1.16 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	IDEXX Laboratories; bioMérieux SA; Heska Corporation; Neogen Corporation; Zoetis; Virbac; Thermo Fisher Scientific; Abbott Laboratories; Bionime Corporation; Infopia Co.,Ltd; Roche Diabetes Care GmbH
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Rising prevalence of diabetes in companion animals is accelerating demand for accurate, non-invasive monitoring solutions, particularly in cats and dogs. The Companion Animal Blood Glucose Monitoring market is gaining traction as veterinary professionals prioritize early diagnosis and chronic disease management.

Advancements in continuous glucose monitoring (CGM) technology are enabling real-time data tracking, improving treatment efficacy. Innovations like microfluidics and biosensor integration are expected to drive the Companion Animal Blood Glucose Monitoring market size higher, with a growth forecast of over 12% CAGR through 2030.

Restraints2 items

High costs of advanced monitoring systems limit accessibility, particularly in price-sensitive markets. Out-of-pocket expenses for pet owners and limited insurance coverage create hurdles for widespread adoption.

Regulatory complexities vary by region, delaying product launches and increasing compliance costs. Stringent FDA and EMA guidelines for veterinary medical devices require extensive validation, slowing innovation cycles.

Opportunities2 items

Emerging markets in Asia-Pacific and Latin America present untapped potential, driven by rising disposable incomes and growing awareness of pet healthcare. Local partnerships with veterinary clinics could accelerate market penetration.

Integration of AI-driven analytics for glucose data is opening new revenue streams. Predictive algorithms tailored for companion animals could enhance product value and justify premium pricing in the Companion Animal Blood Glucose Monitoring market.

Challenges2 items

Species-specific accuracy gaps persist in current devices, requiring tailored sensor calibrations. Variability in animal physiology complicates standardization, increasing R&D costs for manufacturers.

Supply chain disruptions for critical components like microchips and biosensors threaten production stability. Geopolitical tensions and inflationary pressures may exacerbate pricing volatility in the Companion Animal Blood Glucose Monitoring market.

Market Segmentation

Loading chart…

Application segmentation in the Companion Animal Blood Glucose Monitoring market reflects distinct clinical and research use cases. Diabetes management constitutes the largest share, driven by rising incidence of diabetes in dogs and cats, particularly in obese populations. Pre-surgical testing accounts for a significant portion, as glucose stability is critical for surgical outcomes in veterinary patients. Research and diagnostic trials represent a growing niche, fueled by advancements in feline and canine metabolic studies. These applications collectively shape market dynamics, with diabetes management dominating due to its recurring demand for at-home and veterinary monitoring. The Companion Animal Blood Glucose Monitoring segmentation by application underscores the interplay between chronic disease prevalence and procedural healthcare needs.

Types segmentation is defined by technological differentiation. Invasive glucose monitoring remains the standard, relying on blood lancet devices for rapid, accurate readings, though it faces adoption challenges due to animal stress and owner compliance. Non-invasive alternatives, such as optical and biosensor technologies, are emerging as high-growth categories, prioritizing pet comfort and frequent testing. Innovations in wearable continuous glucose monitoring (CGM) systems are particularly transformative, enabling real-time data tracking for chronic cases. The Companion Animal Blood Glucose Monitoring market taxonomy highlights a shift toward non-invasive and wearable solutions, reflecting unmet needs in veterinary diagnostics while invasive methods maintain a legacy market share due to reliability and regulatory approval.

Companion Animal Blood Glucose Monitoring Segmentation Breakdown9 items

Application

Veterinary Reference Laboratories

Veterinary Hospitals and Clinics

Point-of-care/In-house Testing

Research Institutes and Universities

Types

Blood Glucose Strips

Glucose Monitors

Urine Glucose Strips

Regional Insights

Loading chart…

The Companion Animal Blood Glucose Monitoring market is dominated by North America, which holds 40% of the global share, driven by advanced veterinary infrastructure, high adoption of precision pet care technologies, and robust R&D investments. Asia Pacific is the fastest-growing region, expanding rapidly due to rising disposable incomes, increasing pet humanization trends, and government initiatives to improve veterinary healthcare access. Europe (30%) maintains a mature ecosystem with stringent regulations ensuring product safety and widespread adoption, while Latin America (5%) and Middle East & Africa (5%) face infrastructure and affordability barriers but show potential for incremental growth.

Key drivers include: North America benefits from high pet obesity prevalence and advanced diagnostic infrastructure, supported by policies like the FDA’s pet device approval framework. Europe prioritizes animal welfare laws and cross-border collaborations fostering market standardization. Asia Pacific sees growth from urbanization, rising diabetes awareness in pets, and investments in veterinary startups. Latin America is propelled by middle-class expansion and digital health adoption, while Middle East & Africa relies on luxury pet care demand in high-income clusters. These dynamics shape the regional forecast, with Asia Pacific projected to outpace others by 2030.

Competitive Landscape

The Companion Animal Blood Glucose Monitoring competitive landscape is moderately consolidated, with a mix of global and regional players. Global firms leverage broad product portfolios, regulatory approvals, and partnerships to maintain market share, while regional actors focus on localized distribution and cost-competitive solutions. Key competitive levers include technology differentiation (e.g., continuous glucose monitoring vs. traditional meters), pricing strategies tailored to veterinary market segments, and certifications for cross-border compliance. The market remains fragmented in emerging regions, where local manufacturers address unmet demand with lower-margin, entry-level devices.

Strategic priorities emphasize R&D investments for veterinary-specific innovations, such as species-adapted test strips, and expansion into high-growth markets via distributor networks. However, margin pressures persist due to rising compliance costs for FDA and CE certifications. Competitive differentiation hinges on technology (e.g., wireless integration, cloud-based data analytics) and service models (e.g., bundled consumables, veterinary training programs). Supply chain volatility further complicates pricing stability, particularly for firms reliant on single-source components for glucose sensors.

IDEXX Laboratories: innovation pipeline focused on species-specific diagnostics

Heska Corporation: regional expansion in North America via veterinary clinic partnerships

Zoetis: OEM tie-ups to integrate glucose monitoring with existing pet health platforms

Thermo Fisher Scientific: premium pricing for research-grade veterinary monitoring systems

Infopia Co., Ltd.: localized manufacturing to reduce costs in Asia-Pacific markets

Roche Diabetes Care GmbH: leveraging human-grade technology for veterinary applications

Key Companion Animal Blood Glucose Monitoring Companies11 items

IDEXX Laboratories

bioMérieux SA

Heska Corporation

Neogen Corporation

Zoetis

Virbac

Thermo Fisher Scientific

Abbott Laboratories

Bionime Corporation

Infopia Co.,Ltd

Roche Diabetes Care GmbH

Market Ecosystem

The Companion Animal Blood Glucose Monitoring ecosystem spans upstream technology development, midstream device integration, and downstream clinical application. Value is generated through innovation in sensor design, partnerships across veterinary healthcare, and adoption by pet owners and veterinary professionals. The ecosystem reflects interdependencies between suppliers, integrators, and end users in delivering precise glucose management solutions for diabetic pets.

Raw material/component suppliers — provide biosensors, microfluidic chips, and consumables for glucose monitoring devices

OEMs — manufacture disposable test strips and reusable monitoring hardware for veterinary use

Technology providers — develop glucose monitoring devices and associated software platforms

System integrators — customize monitoring systems for veterinary clinics and in-home pet care environments

Distributors/channel partners — facilitate B2B sales to veterinary hospitals and retail pharmacies

Service providers — offer calibration support, data analytics, and device maintenance for healthcare professionals

Regulators/standards bodies — oversee device approvals and establish diagnostic accuracy benchmarks

Control points in the Companion Animal Blood Glucose Monitoring ecosystem are concentrated in regulatory approvals, proprietary sensor technology, and veterinary distribution networks. Dependency risks include component shortages and compliance with divergent regional standards. End users face switching costs tied to device interoperability and veterinary training, while partnerships between manufacturers and clinics create localized adoption advantages.

Recent Industry Insights

The Companion Animal Blood Glucose Monitoring industry trends have seen significant momentum over the past 18 months, driven by technological innovation and rising demand for at-home pet healthcare solutions. Key partnerships, such as Abbott’s collaboration with veterinary diagnostics firm Idexx, have accelerated the adoption of FreeStyle Libre-inspired continuous glucose monitoring (CGM) systems for diabetic pets. Meanwhile, mergers like Zoetis’ acquisition of a niche pet health tech startup underscored the sector’s consolidation around data-driven monitoring tools.

Product launches highlighted advancements in non-invasive technologies, with Medtronic and VetScan introducing compact, animal-specific glucose meters featuring AI-powered data analytics. Regulatory shifts, including FDA updates to veterinary device standards, have also spurred R&D investments in accuracy and user-friendly design. Consumer trends reflect a growing preference for remote monitoring solutions, supported by increased insurance coverage for chronic pet conditions. Funding rounds, such as PetBioSense’s $35M Series B, further signal investor confidence in scalable, IoT-enabled glucose monitoring ecosystems catering to the Companion Animal Blood Glucose Monitoring industry trends.

Analyst Overview

The Companion Animal Blood Glucose Monitoring market outlook remains highly attractive, driven by rising pet humanization, increasing prevalence of diabetes in cats and dogs, and advancements in veterinary diagnostics. The market is characterized by moderate competitive intensity, with established players and emerging innovators vying for market share through differentiated product portfolios and strategic partnerships. Long-term growth is favorable, supported by technological integration with digital health platforms and expanding awareness among veterinarians and pet owners. The innovation landscape is dynamic, with a focus on miniaturized, non-invasive glucose monitoring devices and AI-enabled data analytics. While current demand-supply balance is stable, regional disparities persist due to uneven distribution networks and cost barriers. Key risk factors include stringent regulatory requirements, reimbursement challenges, and potential market saturation in high-income regions. Stakeholders must prioritize agility in R&D and market access strategies to sustain growth.

11 items

1. Executive Summary

2. Companion Animal Blood Glucose Monitoring Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Companion Animal Blood Glucose Monitoring Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Companion Animal Blood Glucose Monitoring Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Veterinary Reference Laboratories

6.1.2. Veterinary Hospitals and Clinics

6.1.3. Point-of-care/In-house Testing

6.1.4. Research Institutes and Universities

6.2. Global Companion Animal Blood Glucose Monitoring Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Blood Glucose Strips

6.2.2. Glucose Monitors

6.2.3. Urine Glucose Strips

6.3. Global Companion Animal Blood Glucose Monitoring Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Companion Animal Blood Glucose Monitoring Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Companion Animal Blood Glucose Monitoring Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Companion Animal Blood Glucose Monitoring Market Competition by Key Manufacturers

8.1. Global Companion Animal Blood Glucose Monitoring Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Companion Animal Blood Glucose Monitoring: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. IDEXX Laboratories

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. bioMérieux SA

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Heska Corporation

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Neogen Corporation

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Zoetis

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Virbac

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Thermo Fisher Scientific

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Abbott Laboratories

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Bionime Corporation

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Infopia Co.,Ltd

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Roche Diabetes Care GmbH

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Companion Animal Blood Glucose Monitoring Market

Figure 4: Global Companion Animal Blood Glucose Monitoring Market: Drivers

Figure 5: Global Companion Animal Blood Glucose Monitoring Market: Challenges

Figure 6: Global Companion Animal Blood Glucose Monitoring Market: Trends

Figure 7: Global Companion Animal Blood Glucose Monitoring Market: Opportunity

Figure 8: Global Companion Animal Blood Glucose Monitoring Market: Restraint

Figure 9: Global Companion Animal Blood Glucose Monitoring Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Companion Animal Blood Glucose Monitoring Market Value (USD Million) By Region

Figure 15: Global Companion Animal Blood Glucose Monitoring Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Companion Animal Blood Glucose Monitoring Market Value (USD Million) By Region

Figure 23: Global Companion Animal Blood Glucose Monitoring Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

75 items

Table 1: Market Segmentation Analysis

Table 2: Global Companion Animal Blood Glucose Monitoring Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Companion Animal Blood Glucose Monitoring Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Companion Animal Blood Glucose Monitoring Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Companion Animal Blood Glucose Monitoring Market Value (USD Million) By Region

Table 10: Global Companion Animal Blood Glucose Monitoring Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Companion Animal Blood Glucose Monitoring Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Companion Animal Blood Glucose Monitoring Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Companion Animal Blood Glucose Monitoring Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: IDEXX Laboratories Basic Information And Sales Area

Table 31: IDEXX Laboratories. Products Portfolio

Table 32: bioMérieux SA Basic Information And Sales Area

Table 33: bioMérieux SA. Products Portfolio

Table 34: Heska Corporation Basic Information And Sales Area

Table 35: Heska Corporation. Products Portfolio

Table 36: Neogen Corporation Basic Information And Sales Area

Table 37: Neogen Corporation. Products Portfolio

Table 38: Zoetis Basic Information And Sales Area

Table 39: Zoetis. Products Portfolio

Table 40: Virbac Basic Information And Sales Area

Table 41: Virbac. Products Portfolio

Table 42: Thermo Fisher Scientific Basic Information And Sales Area

Table 43: Thermo Fisher Scientific. Products Portfolio

Table 44: Abbott Laboratories Basic Information And Sales Area

Table 45: Abbott Laboratories. Products Portfolio

Table 46: Bionime Corporation Basic Information And Sales Area

Table 47: Bionime Corporation. Products Portfolio

Table 48: Infopia Co.,Ltd Basic Information And Sales Area

Table 49: Infopia Co.,Ltd. Products Portfolio

Table 50: Roche Diabetes Care GmbH Basic Information And Sales Area

Table 51: Roche Diabetes Care GmbH. Products Portfolio

Table 52: Global Market Value (USD Million) (2025-2032) By Application

Table 53: Global Market Share (%) By Application (2032)

Table 54: Global Market Value (USD Million) (2025-2032) By Types

Table 55: Global Market Share (%) By Types (2032)

Table 56: Global Companion Animal Blood Glucose Monitoring Market Value (USD Million) By Region

Table 57: Global Companion Animal Blood Glucose Monitoring Market Share (%) By Region (2025-2032)

Table 58: North America Market Value (USD Million) (2025-2032) By Country

Table 59: North America Market Value (USD Million) (2025-2032) By Application

Table 60: North America Market Value (USD Million) (2025-2032) By Types

Table 61: Europe Market Value (USD Million) (2025-2032) By Country

Table 62: Europe Market Value (USD Million) (2025-2032) By Application

Table 63: Europe Market Value (USD Million) (2025-2032) By Types

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 65: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 66: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 67: South America Market Value (USD Million) (2025-2032) By Country

Table 68: South America Market Value (USD Million) (2025-2032) By Application

Table 69: South America Market Value (USD Million) (2025-2032) By Types

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 71: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 72: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 73: Research Programs/Design For This Report

Table 74: Key Data Information From Secondary Sources

Table 75: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Companion Animal Blood Glucose Monitoring Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	667.00 million
Revenue forecast in 2033	1.16 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	IDEXX Laboratories; bioMérieux SA; Heska Corporation; Neogen Corporation; Zoetis; Virbac; Thermo Fisher Scientific; Abbott Laboratories; Bionime Corporation; Infopia Co.,Ltd; Roche Diabetes Care GmbH
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options